Organovo Holdings Inc (ONVO)
1.05
-0.05
(-4.55%)
USD |
NASDAQ |
Apr 22, 16:00
1.00
-0.05
(-4.76%)
After-Hours: 20:00
Organovo Holdings Free Cash Flow (Quarterly): -3.522M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.522M |
| September 30, 2023 | -3.176M |
| June 30, 2023 | -5.326M |
| March 31, 2023 | -4.895M |
| December 31, 2022 | -3.085M |
| September 30, 2022 | -2.336M |
| June 30, 2022 | -2.488M |
| March 31, 2022 | -1.594M |
| December 31, 2021 | -3.489M |
| September 30, 2021 | -2.172M |
| June 30, 2021 | -1.607M |
| March 31, 2021 | -2.225M |
| December 31, 2020 | -1.785M |
| September 30, 2020 | -7.148M |
| June 30, 2020 | -2.57M |
| March 31, 2020 | -3.209M |
| December 31, 2019 | -0.583M |
| September 30, 2019 | -5.155M |
| June 30, 2019 | -5.935M |
| March 31, 2019 | -5.119M |
| December 31, 2018 | -3.978M |
| September 30, 2018 | -4.335M |
| June 30, 2018 | -7.022M |
| March 31, 2018 | -5.747M |
| December 31, 2017 | -6.478M |
| Date | Value |
|---|---|
| September 30, 2017 | -6.194M |
| June 30, 2017 | -10.73M |
| March 31, 2017 | -7.519M |
| December 31, 2016 | -7.659M |
| September 30, 2016 | -6.808M |
| June 30, 2016 | -8.553M |
| March 31, 2016 | -7.935M |
| December 31, 2015 | -7.076M |
| September 30, 2015 | -9.076M |
| June 30, 2015 | -7.43M |
| March 31, 2015 | -6.26M |
| December 31, 2014 | -4.605M |
| September 30, 2014 | -6.65M |
| June 30, 2014 | -3.603M |
| March 31, 2014 | -5.521M |
| December 31, 2013 | -3.885M |
| September 30, 2013 | -3.606M |
| June 30, 2013 | -2.826M |
| December 31, 2012 | -2.080M |
| September 30, 2012 | -2.475M |
| June 30, 2012 | -1.933M |
| March 31, 2012 | -3.561M |
| December 31, 2011 | -0.0099M |
| September 30, 2011 | -0.0006M |
| June 30, 2011 | -0.0299M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-7.148M
Minimum
Sep 2020
-0.583M
Maximum
Dec 2019
-3.279M
Average
-3.085M
Median
Dec 2022
Free Cash Flow (Quarterly) Benchmarks
| Marinus Pharmaceuticals Inc | -27.03M |
| Cartesian Therapeutics Inc | -23.35M |
| Adial Pharmaceuticals Inc | -1.223M |
| Longeveron Inc | -4.256M |
| Viracta Therapeutics Inc | -10.03M |